Acepodia Announces Nobel Laureate Carolyn Bertozzi, Ph.D., as Chief Scientific Advisor

Acepodia Announces Emerging Stock Listing on The Taipei Exchange

Acepodia Secures $100 Million Series D Financing to Advance First-In-Class Cell Therapies with Antibody-Cell Conjugation (ACC) Platform

Acepodia Announces First Patient Dosed in Phase 1 Clinical Trial of ACE1831, an Anti-CD20 Armed Allogeneic Gamma Delta T-cell Therapy in Development to Treat Patients with Non- Hodgkin’s Lymphoma

PR Newswire

Acepodia to Present Preclinical Data of Gamma Delta T cell Therapy Candidate, ACE2016, an off-the-shelf EGFR-targeting γδ2 T cell therapy against EGFR-expressing solid tumors

PR Newswire

Acepodia to Present Preclinical Data on its Gamma Delta T cell Therapy Candidate, ACE1831, at 2022 SITC Annual Meeting

PR Newswire

Acepodia Congratulates Laureates of the 2022 Nobel Prize in Chemistry and Shares the Excitement to Translate Click Chemistry into a New Class of Investigational Therapies

PR Newswire

Acepodia Announces FDA Clearance of IND Application for ACE1831, an Anti-CD20 Armed Allogeneic gamma delta T-cell Therapy Candidate to Treat Patients with non-Hodgkin's Lymphoma

PR Newswire

Acepodia Raises $109 Million Series C Financing to Advance Development of First-in-Class Antibody Cell Effector Therapies

GlobeNewswire

Allogeneic cetuximab- armed gamma delta T cells using antibody- cell conjugation technology for the treatment of EGFR- expressing solid tumors

Li H- K, et al. J Immunother Cancer 2025;13:e010500. doi:10.1136/jitc-2024-010500

Allogeneic cetuximab-armed gamma delta T cells using antibody-cell conjugation technology for the treatment of EGFR-expressing solid tumors
Hao-Kang Li , Tai-Sheng Wu , Ying Ru 1, Yi-Chiu Kuo , Chia-Yun Lee , Pei-Ju Leng , Yi-Chun Hsieh , Yun-Jung Chiang , Zih-Fei Cheng , Yan-Liang Lin , Shih-Chia Hsiao , Sai-Wen Tang

A Novel Allogeneic Rituximab-Conjugated Gamma Delta T Cell Therapy for the Treatment of Relapsed/Refractory B-Cell Lymphoma

Cancers 2023, 15(19), 4844
Hao-Kang Li,Tai-Sheng Wu,Yi-Chiu Kuo,Ching-Wen Hsiao,Hsiu-Ping Yang, Hsiu-Ping Yang, Chia-Yun Lee, Pei-Ju Leng, Yun-Jung Chiang, Zih-Fei Cheng, Sen-Han Yang, Yan-Liang Lin, Li-Yu Chen, Ciao-Syuan Chen, Yu-Ju Chen, Shih-Chia Hsiao, Sai-Wen Tang

Acepodia Presents Preclinical Data on its gamma delta T cell Therapy Candidate ACE1831 at 2022 AACR Meeting